Examining the effects of AI on college students' writing and cognitive abilities
A Randomized Controlled Trial on the Impact of Using Generative Artificial Intelligence on Analytical Writing Performance and Cognitive Abilities
This study tests if using AI tools like ChatGPT can help college students write better and think more effectively while they write.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 1 site (Heidelberg) |
| Trial ID | NCT06511102 on ClinicalTrials.gov |
What this trial studies
This randomized controlled lab experiment investigates how the use of artificial intelligence, specifically ChatGPT, influences college students' performance in analytical writing and their cognitive effort during the writing process. Participants will be divided into two groups: one using AI assistance and the other writing without it. The study will utilize eye-tracking technology and functional near-infrared spectroscopy (fNIRS) to monitor gaze activities and brain activity, respectively, over a 1.5-hour session. The goal is to determine if AI support enhances writing performance and cognitive engagement.
Who should consider this trial
Good fit: Ideal candidates for this study are full-time university students who are proficient in English and regularly use computers.
Not a fit: Patients who wear glasses or have eye impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how AI tools can enhance academic performance and cognitive processes in students.
How similar studies have performed: While the use of AI in educational settings is gaining traction, this specific approach to measuring cognitive effects during writing with AI assistance is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Full-time university student. * Able to read and write in English. * Use the computer most days of the week. * Have not taken, nor currently preparing for, the Graduate Record Examinations (GRE). * Do not wear glasses (contact lenses are allowed). * Have no eye impairment. * Not currently taking any opioids, epinephrine, or anti-hypertensive drugs. * During the experiment, not wearing any makeup around the eyes.
Where this trial is running
Heidelberg
- Core Facility for Neuroscience of Self-Regulation, Heidelberg University — Heidelberg, Germany (Recruiting)
Study contacts
- Principal investigator: Till Bärnighausen — Heidelberg Institute of Global Health
- Study coordinator: Simiao Chen
- Email: simiao.chen@uni-heidelberg.de
- Phone: +49 15252694007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.